Angiogenesis, the formation on new blood vessels, plays a critical role in a number of physiological and pathological processes, including wound healing, tumor growth, and rheumatoid arthritis (RA). Previously Dr. Koch's lab has shown that the soluble adhesion molecules E-selectin and vascular cell adhesion molecule-1 are present in RA synovial fluid and act as proangiogenic factors. Junctional adhesion molecules (JAMs) are novel members of the Immunoglobulin supergene family that are expressed by various cell types, including endothelial cells, and play critical roles in controlling vascular permeability, leukocyte retention, and trans-endothelial migration. Recent studies have also demonstrated roles for membrane bound JAM-A and JAM-C in mediating angiogenesis. To date, the role of soluble JAMs (sJAMs) in angiogenesis has not been determined. We therefore hypothesize that sJAMs play critical roles in mediating angiogenesis. To test this hypothesis we will (1) examine the role of sJAM-A, -B, and -C in angiogenesis by designing an enzyme- linked immunosorbent assay (ELISA) to determine the levels of sJAMs in normal blood, RA blood, and RA synovial fluid. Once the presence of sJAMs has been demonstrated, we will assess their ability to induce human dermal microvascular endothelial cell (HMVEC) chemotaxis in vitro. We will then determine if sJAMs induce HMVEC tube formation on Matrigel in vitro and in Matrigel plugs in vivo. (2) We will then determine the signaling pathways and receptors by which sJAMs mediate angiogenesis by stimulating HMVECs with sJAMs and examining specific pathways by Western blot and immunofluorescence. (3) Finally, we will determine the mechanisms by which sJAMs mediate angiogenesis by performing HMVEC chemotaxis assays in vitro in the presence and absence of signaling inhibitors. These results will be confirmed using Matrigel tube formation assays in vitro and Matrigel plug assays in vivo with sJAMs in the presence and absence of signaling inhibitors directed against the signaling molecules determined above.

Public Health Relevance

Elucidating the role of sJAMs in angiogenesis and the mechanisms by which they work may provide another route for modulating angiogenesis in tumor growth, cardiovascular disease, and RA.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL094017-01A1
Application #
7666398
Study Section
Special Emphasis Panel (ZRG1-F10-H (21))
Program Officer
Meadows, Tawanna
Project Start
2009-05-01
Project End
2012-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
1
Fiscal Year
2009
Total Cost
$50,054
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Mor-Vaknin, Nirit; Saha, Anjan; Legendre, Maureen et al. (2017) DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nat Commun 8:14252
Rabquer, Bradley J; Hou, Yong; Ruth, Jeffrey H et al. (2012) H-2g, a glucose analog of blood group H antigen, mediates monocyte recruitment in vitro and in vivo via IL-8/CXCL8. Open Access Rheumatol 4:93-98
Rabquer, Bradley J; Koch, Alisa E (2012) Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts. Curr Rheumatol Rep 14:56-63
Rabquer, Bradley J; Tsou, Pei-Suen; Hou, Yong et al. (2011) Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther 13:R18
Marotte, Hubert; Tsou, Pei-Suen; Rabquer, Bradley J et al. (2011) Blocking of interferon regulatory factor 1 reduces tumor necrosis factor ?-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory factor 1 Arthritis Rheum 63:3253-62
Ruth, Jeffrey H; Arendt, Monica D; Amin, M Asif et al. (2010) Expression and function of CXCL16 in a novel model of gout. Arthritis Rheum 62:2536-44
Rabquer, Bradley J; Amin, Mohammad A; Teegala, Nanditha et al. (2010) Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol 185:1777-85
Amin, M Asif; Rabquer, Bradley J; Mansfield, Pamela J et al. (2010) Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases. Ann Rheum Dis 69:2204-12